Literature DB >> 11425448

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma.

A A Sandberg1, J A Bridge.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11425448     DOI： 10.1007/3-540-30792-3_7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  9 in total

1.  Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.

Authors:  Didier Jean; Emilie Thomas; Elodie Manié; Annie Renier; Aurélien de Reynies; Céline Lecomte; Pascal Andujar; Jocelyne Fleury-Feith; Françoise Galateau-Sallé; Marco Giovannini; Jessica Zucman-Rossi; Marc-Henri Stern; Marie-Claude Jaurand
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Authors:  Geula Klorin; Ester Rozenblum; Oleg Glebov; Robert L Walker; Yoonsoo Park; Paul S Meltzer; Ilan R Kirsch; Frederic J Kaye; Anna V Roschke
Journal:  Cancer Genet       Date:  2013-07-05

3.  Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.

Authors:  Ben Davidson; Lina Vintman; Eyal Zcharia; Carlos Bedrossian; Aasmund Berner; Søren Nielsen; Neta Ilan; Israel Vlodavsky; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  In vitro and in vivo characterization of highly purified human mesothelioma derived cells.

Authors:  Alice Melotti; Antonio Daga; Daniela Marubbi; Annalisa Zunino; Luciano Mutti; Giorgio Corte
Journal:  BMC Cancer       Date:  2010-02-22       Impact factor: 4.430

Review 5.  Current therapy for malignant mesothelioma.

Authors:  W Roy Smythe
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.945

6.  Expression of cancer-associated molecules in malignant mesothelioma.

Authors:  Ben Davidson
Journal:  Biomark Insights       Date:  2007-05-30

7.  Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.

Authors:  Tomoyuki Hida; Shinji Matsumoto; Makoto Hamasaki; Kunimitsu Kawahara; Tohru Tsujimura; Kenzo Hiroshima; Toshiaki Kamei; Kenichi Taguchi; Akinori Iwasaki; Yoshinao Oda; Hiroshi Honda; Kazuki Nabeshima
Journal:  Cancer Sci       Date:  2015-10-15       Impact factor: 6.716

8.  Molecular characterization of localized pleural mesothelioma.

Authors:  Yin P Hung; Fei Dong; Adrian M Dubuc; Paola Dal Cin; Raphael Bueno; Lucian R Chirieac
Journal:  Mod Pathol       Date:  2019-08-01       Impact factor: 7.842

9.  Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.

Authors:  Tomoaki Naka; Yutaka Hatanaka; Katsuji Marukawa; Hiromi Okada; Kanako C Hatanaka; Jun Sakakibara-Konishi; Satoshi Oizumi; Yasuhiro Hida; Kichizo Kaga; Tomoko Mitsuhashi; Yoshihiro Matsuno
Journal:  Diagn Pathol       Date:  2016-04-18       Impact factor: 2.644
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.